D. Gardner

发表

International consensus study of antipsychotic dosing.

R. Baldessarini, D. Gardner, A. Murphy, 2010, The American journal of psychiatry.

Psychopharmacological treatment options for global child and adolescent mental health: the WHO essential medicines lists.

S. Kutcher, D. Gardner, A. Murphy, 2008, Journal of the American Academy of Child and Adolescent Psychiatry.

Alternatives to Atypical Antipsychotics for the Management of Dementia-Related Agitation

K. Rabheru, D. Gardner, Michael J. Passmore, 2008, Drugs & aging.

Treatment Recommendations for Tardive Dyskinesia

G. Remington, M. Edwards, D. Martino, 2019, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Bloom Program pharmacy teams’ experiences providing mental health services during the COVID-19 pandemic

D. Gardner, A. Murphy, Katherine Simon, 2021, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.

Patient care activities by community pharmacists in a capitation funding model mental health and addictions program

D. Gardner, A. Murphy, Lisa M. Jacobs, 2018, BMC Psychiatry.

From personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness and addictions in community pharmacies

R. Martin-Misener, S. Kutcher, T. Chen, 2016, BMC Health Services Research.

Partnering to enhance mental health care capacity in communities

R. Martin-Misener, S. Kutcher, D. Gardner, 2015, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.

Community pharmacists and the assessment and management of suicide risk

S. Kutcher, T. Chen, D. Gardner, 2015, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.

Youth, Caregiver, and Prescriber Experiences of Antipsychotic-Related Weight Gain

S. Kutcher, D. Gardner, A. Murphy, 2013, ISRN obesity.

Antipsychotics and their Side Effects: Sialorrhea

R. Baldessarini, D. Gardner, M. Teehan, 2010 .

Drug and resource use evaluation of risperidone and olanzapine in inpatients with outpatient follow-up

D. Gardner, L. Grasswick, A. Woodman, 1999, European Neuropsychopharmacology.

Switching between Clozapine and Risperidone Treatment

M. Tohen, R. Baldessarini, D. Gardner, 1997, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Pilot Testing the Theoretical Framework of Acceptability in a Process Evaluation of a Community Pharmacy–Based Men’s Mental Health Promotion Program

D. Gardner, A. Murphy, 2019, SAGE Open.

Pharmacists' acceptability of a men's mental health promotion program using the Theoretical Framework of Acceptability

D. Gardner, A. Murphy, 2019, AIMS public health.

Pharmacists’ performance in a telephone-based simulated patient study after a mental health capacity-building program

R. Martin-Misener, S. Kutcher, D. Gardner, 2015, International Journal of Clinical Pharmacy.

Driving performance assessments for benzodiazepine receptor agonist-related impairment: a scoping review protocol.

Heather F. Neyedli, M. Macdonald, R. Martin-Misener, 2020, JBI evidence synthesis.

The Pharmacological Management of Oppositional Behaviour, Conduct Problems, and Aggression in Children and Adolescents with Attention-Deficit Hyperactivity Disorder, Oppositional Defiant Disorder, and Conduct Disorder: A Systematic Review and Meta-Analysis. Part 1: Psychostimulants, Alpha-2 Agonists

D. Gorman, T. Pringsheim, D. Gardner, 2015, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Clinical Experience: Education, Illustrations and Antidepressant Treatment Compliance

D. Gardner, 2002 .

Olanzapine for Patients with Treatment-Resistant Schizophrenia: A Naturalistic Case-Series Outcome Study

Janet A. Flinn, S. Dursun, D. Gardner, 1999, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Evidence-based decisions about herbal products for treating mental disorders.

D. Gardner, 2002, Journal of psychiatry & neuroscience : JPN.

Anxiety Disorders in Children and Adolescents: Clinical and Related Issues in Pharmacological Treatment*

S. Kutcher, D. Gardner, S. Reiter, 1992, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

A protocol for a randomized controlled trial comparing Sleepwell, EMPOWER, and treatment-as-usual for benzodiazepine receptor agonist discontinuation in older adults: the your answers when needing sleep in New Brunswick (YAWNS NB) study

D. Gardner, A. Murphy, S. Magalhaes, 2022, Exploratory research in clinical and social pharmacy.

Sumatriptan Contraindications and the Serotonin Syndrome

L. Lynd, D. Gardner, 1998, The Annals of pharmacotherapy.

D. Gorman, T. Pringsheim, D. Gardner, 2015, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Conversions from clozapine to other antipsychotic drugs.

R. Baldessarini, D. Gardner, D. Garver, 1995, Archives of general psychiatry.

Educating Residents About Cannabis: Results of a Needs Assessment

D. Gardner, Lara Hazelton, Chelcie Soroka, 2021, Academic Psychiatry.

Developing a Collaborative Practice

D. Gardner, B. Power, 2007 .

Quetiapine use in adults in the community: a population-based study in Alberta, Canada

T. Pringsheim, D. Gardner, L. Cooke, 2016, BMJ Open.

The successful pharmacological treatment of adolescents and young adults with borderline personality disorder: a preliminary open trial of flupenthixol.

G. Papatheodorou, S. Kutcher, D. Gardner, 1995, Journal of psychiatry & neuroscience : JPN.

A case of risperidone overdose in early schizophrenia: a review of potential complications.

D. Gardner, L. Kopala, B. Dillman, 1998, Journal of psychiatry & neuroscience : JPN.

Monitoring and Management of Metabolic Risk Factors in Outpatients Taking Antipsychotic Drugs: A Controlled Study

D. Gardner, Amber Jennex, 2008, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Dispensed prescriptions for quetiapine and other second-generation antipsychotics in Canada from 2005 to 2012: a descriptive study.

T. Pringsheim, D. Gardner, 2014, CMAJ open.

Data safety monitoring boards and other study methodologies that address subject safety in "high-risk" therapeutic trials in youths.

S. Kutcher, D. Santor, D. Gardner, 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

Modern antipsychotic drugs: a critical overview

R. Baldessarini, D. Gardner, P. Waraich, 2005, Canadian Medical Association Journal.

A survey of Canadian and Australian pharmacists’ stigma of suicide

R. Martin-Misener, S. Doucette, D. Gardner, 2019, SAGE open medicine.

A comparison of antidepressant use in Nova Scotia, Canada and Australia

S. Tett, I. Sketris, D. Gardner, 2008, Pharmacoepidemiology and drug safety.

A retrospective analysis of patient care activities in a community pharmacy mental illness and addictions program.

D. Gardner, A. Murphy, Lauren Haslam, 2020, Research in social & administrative pharmacy : RSAP.

A comparison of factors used by physicians and patients in the selection of antidepressant agents.

N. MacKinnon, D. Gardner, D. Langille, 2007, Psychiatric services.

Tap (Draft) Beer and Monoamine Oxidase Inhibitor Dietary Restrictions

K. Shulman, S. Walker, S. Tailor, 1997, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Incidence of Oculogyric Crisis and Long-Term Outcomes With Second-Generation Antipsychotics in a First-Episode Psychosis Program

P. Tibbo, Zenovia Ursuliak, D. Gardner, 2015, Journal of clinical psychopharmacology.

First case of sialolithiasis associated with atomoxetine.

S. Kutcher, L. Jerome, D. Gardner, 2007, Journal of clinical psychopharmacology.

Policies for Deprescribing: An International Scan of Intended and Unintended Outcomes of Limiting Sedative-Hypnotic Use in Community-Dwelling Older Adults

C. Tannenbaum, J. Silvius, D. Gardner, 2019, Healthcare policy = Politiques de sante.

Pharmacists Prescribing Psychotropic Medications: Is This Really a Good Idea?

D. Gardner, B. Power, M. Gagné, 2008 .

PANCYTOPENIA AND VALPROIC ACID: A DOSE‐RELATED ASSOCIATION

D. Gardner, O. J. Oluboka, D. Haslam, 2000, Journal of the American Geriatrics Society.

The Assessment and Treatment of Antipsychotic-Induced Akathisia

Francesca Morgante, Davide Martino, Lucia Ricciardi, 2018, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Antipsychotic side effects and monitoring implications

D. Gardner, M. Teehan, 2010 .

Clozapine Withdrawal: Serotonergic or Dopaminergic Mechanisms?-Reply

F. Tarazi, R. Baldessarini, D. Gardner, 1997 .

Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders

P. Lalonde, A. Malla, A. Labelle, 2005, Neuropsychiatric disease and treatment.

Canadian Guidelines on Pharmacotherapy for Disruptive and Aggressive Behaviour in Children and Adolescents with Attention-Deficit Hyperactivity Disorder, Oppositional Defiant Disorder, or Conduct Disorder

D. Gorman, K. Boylan, T. Pringsheim, 2015, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Evidence review and clinical guidance for the use of ziprasidone in Canada

V. Taylor, P. Lalonde, A. Malla, 2013, Annals of General Psychiatry.

Competent Psychopharmacology

D. Gardner, 2014, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.

R. Baldessarini, D. Gardner, R. Lasser, 1997, The Journal of clinical psychiatry.

Pharmacist Administration of Long-Acting Injectable Antipsychotics to Community-Dwelling Patients: A Scoping Review

D. Gardner, A. Murphy, L. Gillis, 2023, Pharmacy.

The relationship between bipolar disorder and type 2 diabetes: More than just co-morbid disorders

M. Alda, D. Gardner, C. Calkin, 2013, Annals of medicine.

System struggles and substitutes: A qualitative study of general practitioner and psychiatrist experiences of prescribing antipsychotics to children and adolescents

S. Kutcher, D. Gardner, A. Murphy, 2015, Clinical child psychology and psychiatry.

A Qualitative Study of Antipsychotic Medication Experiences of Youth.

S. Kutcher, D. Gardner, A. Murphy, 2015, Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent.

Prescribing trends of antipsychotics in youth receiving income assistance: results from a retrospective population database study

S. Kutcher, D. Gardner, A. Murphy, 2013, BMC Psychiatry.

A Comparison of Benzodiazepine and Related Drug Use in Nova Scotia and Australia

S. Tett, I. Sketris, D. Gardner, 2008, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Community pharmacists’ experiences in mental illness and addictions care: a qualitative study

R. Martin-Misener, S. Kutcher, D. Gardner, 2016, Substance Abuse Treatment, Prevention, and Policy.

Survey of Australian and Canadian Community Pharmacists' Experiences With Patients at Risk of Suicide.

L. Salvador-Carulla, R. Martin-Misener, S. Doucette, 2019, Psychiatric services.

An Epidemiologic Study of Psychotropic Medication and Obesity-Related Chronic Illnesses in Older Psychiatric Patients

D. Gardner, S. Kisely, M. Cox, 2009, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review

D. Gardner, A. Murphy, J. Bergman, 2015, BMC Pharmacology and Toxicology.

Implementing Change in Prescribing Practices

S. Kutcher, D. Gardner, A. Murphy, 2015 .

A theory-informed approach to mental health care capacity building for pharmacists

R. Martin-Misener, S. Kutcher, D. Gardner, 2014, International Journal of Mental Health Systems.

Pharmacy students’ experiences in provision of community pharmacy mental health services

R. Martin-Misener, S. Kutcher, D. Gardner, 2014, Canadian Pharmacists Journal / Revue des Pharmaciens du Canada.

Physical Health and Drug Safety in Individuals with Schizophrenia

Z. Ismail, M. Kelly, T. Pringsheim, 2017, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Recommendations , Physical Health and Drug Safety Antipsychotic Dosing and Polypharmacy

Z. Ismail, M. Kelly, T. Pringsheim, 2017 .

Adjunctive treatment with quetiapine for major depressive disorder: are the benefits of treatment worth the risks?

S. Patten, T. Pringsheim, D. Gardner, 2015, BMJ : British Medical Journal.

Benzodiazepine and Zopiclone Prescription Claims by Older Adults in Nova Scotia: Trends and Concordance with the Screening Tool of Older Persons' potentially inappropriate Prescriptions (STOPP)

I. Sketris, D. Gardner, K. Thompson, 2013 .

A users' guide to understanding therapeutic substitutions.

G. Guyatt, S. Bryan, M. Briel, 2014, Journal of clinical epidemiology.

A scoping review of weight bias by community pharmacists towards people with obesity and mental illness

D. Gardner, A. Murphy, 2016, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.

Effectiveness of contact-based education for reducing mental illness-related stigma in pharmacy students

S. Patten, D. Gardner, Andrew C. H. Szeto, 2012, BMC medical education.

Lithium augmentation in geriatric depressed outpatients: A clinical report

K. Shulman, N. Herrmann, U. Busto, 1994 .

Antipsychotic Drug Dispensations in Older Adults, Including Continuation After a Fall-Related Hospitalization: Identifying Adherence to Screening Tool of Older Persons’ Potentially Inappropriate Prescriptions Criteria Using the Nova Scotia Seniors' Pharmacare Program and Canadian Institute for Healt

I. Sketris, D. Gardner, B. Hill-Taylor, 2018, Current therapeutic research, clinical and experimental.

Effectiveness and cost analysis of methods used to recruit older adult sedative users to a deprescribing randomized controlled trial during the COVID-19 pandemic

D. Gardner, A. Murphy, J. Turner, 2022, Exploratory Research in Clinical and Social Pharmacy.

Reassessing the contraindication of zolmitriptan and serotonin reuptake inhibitors: an evidence‐based pharmacotherapeutic case report

D. Gardner, A. Boutilier, 2003, Journal of Clinical Pharmacy and Therapeutics.

A simulated patient evaluation of pharmacist’s performance in a men’s mental health program

D. Gardner, A. Murphy, 2018, BMC Research Notes.

Community pharmacist services for people with mental illnesses: preferences, satisfaction, and stigma.

D. Gardner, A. Murphy, E. Black, 2009, Psychiatric services.

Pharmacists’ experiences with the Bloom Program application process

D. Gardner, A. Murphy, Lisa M. Jacobs, 2020, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.

Collaborative Mental Health Care: Effective and Rewarding

D. Gardner, 2007 .

Use of selective serotonin reuptake inhibitors and youth suicide: making sense from a confusing story

S. Kutcher, D. Gardner, 2008, Current opinion in psychiatry.

Direct-to-consumer prescription drug advertising in Canada: permission by default?

A. Ostry, D. Gardner, B. Mintzes, 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

An open naturalistic trial of fluoxetine in adolescents and young adults with treatment-resistant major depression.

E. Young, S. Kutcher, D. Gardner, 1992, Journal of child and adolescent psychopharmacology.

Understanding pharmacy staff attitudes and experience relating to suicide

D. Gardner, A. Murphy, Claire L O'reilly, 2021 .

Community pharmacists’ experiences and people at risk of suicide in Canada and Australia: a thematic analysis

L. Salvador-Carulla, R. Martin-Misener, S. Kutcher, 2018, Social Psychiatry and Psychiatric Epidemiology.

Community pharmacists’ attitudes on suicide: A preliminary analysis with implications for medical assistance in dying

R. Martin-Misener, D. Gardner, A. Murphy, 2018, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.

Content validation of a questionnaire measuring basic perinatal depression knowledge

T. Chen, D. Gardner, A. Murphy, 2018, Women & health.

Administration of a Canadian critical appraisal exam to pharmacy students in the Middle East

Emily Black, D. Gardner, K. Wilbur, 2016 .

Is home peak expiratory flow monitoring effective for controlling asthma symptoms?

J. McCormack, D. Gardner, A. McGrath, 2001, Journal of clinical pharmacy and therapeutics.

Website Analytics of a Google Ads Campaign for a Men’s Mental Health Website: Comparative Analysis

D. Gardner, A. Murphy, Andrea Lynn Murphy, 2018, JMIR mental health.

Incidence of extrapyramidal syndromes and tardive dyskinesia.

R. Baldessarini, D. Gardner, 2011, Journal of clinical psychopharmacology.

Antipsychotics and their Side Effects

D. Gardner, M. Teehan, 2010 .

Antipsychotics and their Side Effects by David M. Gardner

R. Baldessarini, D. Gardner, M. Teehan, 2010 .

Antipsychotics and their Side Effects: Prolactin effects

R. Baldessarini, D. Gardner, M. Teehan, 2010 .

Collaborating with youth to inform and develop tools for psychotropic decision making.

Simon Davidson, Stan Kutcher, Andrea Murphy, 2010, Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent.

Dimenhydrinate Abuse among Adolescentsa

S. Kutcher, D. Gardner, 1993, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Choosing an Antidepressant Should Involve the Patient

D. Gardner, 2001 .

Tyramine content of previously restricted foods in monoamine oxidase inhibitor diets.

K. Shulman, S. Walker, S. Tailor, 1996, Journal of clinical psychopharmacology.

Neuroleptic withdrawal in schizophrenic patients.

R. Baldessarini, L. Tondo, R. Wyatt, 1995, Archives of general psychiatry.

The addition of olanzapine to valproate or lithium for acute manic or mixed bipolar episodes reduced manic symptoms

D. Gardner, 2002, Evidence-based mental health.

A simulated patient evaluation of pharmacist’s performance in a men’s mental health program

D. Gardner, A. Murphy, 2018, BMC Research Notes.